Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate

NCT ID: NCT05782296

Last Updated: 2025-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-24

Study Completion Date

2024-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A clinical study designed to validate the safety and performance of the TrueLabor™ device in monitoring labor vs. current standard of care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fetal Heart Rate or Rhythm Abnormality Affecting Newborn During Labor Uterine Contractions Obstetric Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort

Women in active labor following rupture of membranes and placement of an IUPC and/or FSE for obstetric indications

TrueLabor

Intervention Type DEVICE

Non invasive monitoring device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TrueLabor

Non invasive monitoring device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who are on \>=37w0d of gestation
* Maternal age \> 18 years old
* Singleton pregnancy
* Cephalic presentation
* Patient requiring internal monitoring for obstetric indications
* Informed consent

Exclusion Criteria

* Major fetal anomalies
* Patients with implanted electronic devices of any kind
* Patients using exterior electronic devices of any kind during the procedure
* Patients with irritated skin or open wound on the abdominal wall
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

OB-Tools Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ascension Illinois Saint Alexius Residency Program in Obstetrics and Gynecology

Hoffman Estates, Illinois, United States

Site Status

Montefiore Medical Center

The Bronx, New York, United States

Site Status

Meir Medical Center

Kfar Saba, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Israel

Related Links

Access external resources that provide additional context or updates about the study.

https://ob-tools.com/

OB Tools website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CL-00002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VR Scenario for Labor Pain Control
NCT05879848 COMPLETED NA
Amniotic Fluid Analysis
NCT06131684 NOT_YET_RECRUITING EARLY_PHASE1
Trial of Underwater Birth
NCT07313319 NOT_YET_RECRUITING NA